Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

被引：0
|
作者：
Umberto Pensato
Carlo Baraldi
Valentina Favoni
Maria Michela Cainazzo
Paola Torelli
Pietro Querzani
Alessia Pascazio
Davide Mascarella
Eleonora Matteo
Simone Quintana
Gian Maria Asioli
Pietro Cortelli
Giulia Pierangeli
Simona Guerzoni
Sabina Cevoli
机构：
[1] University of Bologna,Department of Biomedical and NeuroMotor Sciences of Bologna
[2] University of Modena and Reggio Emilia,Medical Toxicology
[3] IRCCS Istituto Delle Scienze Neurologiche Di Bologna,Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences
[4] University Hospital of Parma,Headache Centre
[5] AOUPR,Department of Medicine and Surgery
[6] University of Parma,undefined
[7] Neurology Unit,undefined
[8] S. Maria Delle Croci Hospital-AUSL Romagna,undefined
来源：
Neurological Sciences | 2022年 / 43卷
关键词：
Anti-CGRP; Calcitonin gene-related peptide; OnabotulinumtoxinA; Migraine treatment; Prophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1273 / 1280
页数：7
相关论文
共 50 条
  • [21] Real life experience of one year treatment with galcanezumab in chronic migraine with and without medication overuse headache
    Vaghi, G.
    Bitetto, V.
    De Icco, R.
    Guaschino, E.
    Allena, M.
    Tassorelli, C.
    Sances, G.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 109 - 109
  • [22] Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center
    Eleonora Matteo
    Valentina Favoni
    Alessia Pascazio
    Umberto Pensato
    Matteo Benini
    Gian Maria Asioli
    Elena Merli
    Calogero Calabrò
    Pietro Cortelli
    Giulia Pierangeli
    Sabina Cevoli
    Neurological Sciences, 2020, 41 : 483 - 484
  • [23] Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center
    Matteo, Eleonora
    Favoni, Valentina
    Pascazio, Alessia
    Pensato, Umberto
    Benini, Matteo
    Asioli, Gian Maria
    Merli, Elena
    Calabro, Calogero
    Cortelli, Pietro
    Pierangeli, Giulia
    Cevoli, Sabina
    NEUROLOGICAL SCIENCES, 2020, 41 (SUPPL 2) : 483 - 484
  • [24] Degradation of endocannabinoids in chronic migraine and medication overuse headache
    Cupini, L. M.
    Costa, C.
    Sarchielli, P.
    Bari, M.
    Battista, N.
    Eusebi, P.
    Calabresi, P.
    Maccarrone, M.
    NEUROBIOLOGY OF DISEASE, 2008, 30 (02) : 186 - 189
  • [25] Multimorbidity in patients with chronic migraine and medication overuse headache
    D'Amico, Domenico
    Sansone, Emanuela
    Grazzi, Licia
    Giovannetti, Ambra M.
    Leonardi, Matilde
    Schiavolin, Silvia
    Raggi, Alberto
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (06): : 515 - 522
  • [26] Erenumab in chronic migraine with medication overuse Subgroup analysis of a randomized trial
    Tepper, Stewart J.
    Diener, Hans-Christoph
    Ashina, Messoud
    Brandes, Jan Lewis
    Friedman, Deborah I.
    Reuter, Uwe
    Cheng, Sunfa
    Nilsen, Jon
    Leonardi, Dean K.
    Lenz, Robert A.
    Mikol, Daniel D.
    NEUROLOGY, 2019, 92 (20) : E2309 - E2320
  • [27] Degradation of endocannabinoids in chronic migraine and medication overuse headache
    Cupini, Letizia Maria
    Sarchielli, Paola
    Calabresi, Paolo
    Costa, Cinzia
    Bari, Monica
    Battista, Natalia
    Maccarrone, Mauro
    NEUROLOGY, 2007, 68 (12) : A307 - A308
  • [28] Efficacy of erenumab for the treatment of patients with chronic migraine in presence of medication overuse
    Diener, H. -C.
    Ashina, M.
    Brandes, J.
    Friedman, D.
    Reuter, U.
    Tepper, S.
    Cheng, S.
    Leonardi, D.
    Lenz, R.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 472 - 472
  • [29] Efficacy of erenumab for the treatment of patients with chronic migraine in presence of medication overuse
    Tepper, Stewart J.
    Diener, Hans-Christoph
    Ashina, Messoud
    Brandes, Jan L.
    Friedman, Deborah T.
    Reuter, Uwe
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Mikol, Daniel D.
    CEPHALALGIA, 2017, 37 : 33 - 34
  • [30] DOES MEDICATION OVERUSE MATTER? RESPONSE TO ONABOTULINUMTOXINA IN CHRONIC MIGRAINE (CM) PATIENTS WITH OR WITHOUT MEDICATION OVERUSE; UPDATE FROM REAL-LIFE DATA
    Ahmed, F.
    Khalil, M.
    Tanvir, T.
    Buture, A.
    CEPHALALGIA, 2018, 38 : 85 - 86
12345